Skip to main content
. 2021 May 21;12:665621. doi: 10.3389/fimmu.2021.665621

Table 3.

Summary of results from probands and family member testing.

PROBANDS AR IEI XLR IEI AD IEI TOTAL
Probands with LP/P variant on panel 4 (3 homozygous; 1 compound heterozygous) 5 (hemizygous males) 3 (heterozygous) 12
Probands with LP/P variant on WES 6 (homozygous or compound heterozygous) 3 (hemizygous males) 3 (heterozygous) 12
Probands total 10 (homozygous or compound heterozygous) 8 (hemizygous males) 6 (heterozygous) 24
FAMILY MEMBERS AR IEI XLR IEI AD IEI TOTAL
Family members identified as carriers 20 (either through testing or known obligate carrier) 8* (heterozygous females) 0 28
Family member excluded as carriers/affected n/a 1 (maternal aunt of proband) 6* 7

*All were parents of probands.

VUS, variant of unknown significance; WES, whole exome sequencing; AR, autosomal recessive; XLR, X-linked recessive; AD, autosomal dominant; LP/P, likely pathogenic/pathogenic; IEI, inborn error of immunity.